Microvesicles as Potential Ovarian Cancer Biomarkers
作者： Ilaria Giusti , Sandra D’Ascenzo , Vincenza Dolo
DOI: 10.1155/2013/703048
关键词: Biomarker (medicine) 、 Ovarian cancer 、 Pathological 、 Microvesicles 、 microRNA 、 Biology 、 Ovary 、 Immunology 、 Oncology 、 Incidence (epidemiology) 、 Internal medicine 、 Disease
摘要: Although the incidence of ovarian cancer is low (ie, less than 5% in European countries), it is the most lethal gynecologic malignancy and typically has a poor prognosis. To ensure …
hindawi.com参考文章(112)
Ela Shai, David Varon, Development, Cell Differentiation, Angiogenesis—Microparticles and Their Roles in Angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 31, pp. 10- 14 ,(2011) , 10.1161/ATVBAHA.109.200980
Amelie M. Lutz, Jürgen K. Willmann, Charles W. Drescher, Pritha Ray, Frank V. Cochran, Nicole Urban, Sanjiv S. Gambhir, Early Diagnosis of Ovarian Carcinoma: Is a Solution in Sight? Radiology. ,vol. 259, pp. 329- 345 ,(2011) , 10.1148/RADIOL.11090563
Marilena V. Iorio, Manuela Ferracin, Chang-Gong Liu, Angelo Veronese, Riccardo Spizzo, Silvia Sabbioni, Eros Magri, Massimo Pedriali, Muller Fabbri, Manuela Campiglio, Sylvie Ménard, Juan P. Palazzo, Anne Rosenberg, Piero Musiani, Stefano Volinia, Italo Nenci, George A. Calin, Patrizia Querzoli, Massimo Negrini, Carlo M. Croce, MicroRNA gene expression deregulation in human breast cancer. Cancer Research. ,vol. 65, pp. 7065- 7070 ,(2005) , 10.1158/0008-5472.CAN-05-1783
Iván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, Marcus Q. Bernardini, Josep María del Campo, Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls. Clinical & Translational Oncology. ,vol. 14, pp. 15- 20 ,(2012) , 10.1007/S12094-012-0756-8
Marina Bagnoli, Loris De Cecco, Anna Granata, Roberta Nicoletti, Edoardo Marchesi, Paola Alberti, Barbara Valeri, Massimo Libra, Mattia Barbareschi, Francesco Raspagliesi, Delia Mezzanzanica, Silvana Canevari, Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients Oncotarget. ,vol. 6, pp. 9643- 9643 ,(2011) , 10.18632/ONCOTARGET.3998
Peter Carmeliet, Angiogenesis in life, disease and medicine Nature. ,vol. 438, pp. 932- 936 ,(2005) , 10.1038/NATURE04478
Garnet L Anderson, Ovarian cancer biomarker screening: still too early to tell. Women's Health. ,vol. 6, pp. 487- 490 ,(2010) , 10.2217/WHE.10.33
Eun Ji Nam, Heejei Yoon, Sang Wun Kim, Hoguen Kim, Young Tae Kim, Jae Hoon Kim, Jae Wook Kim, Sunghoon Kim, MicroRNA Expression Profiles in Serous Ovarian Carcinoma Clinical Cancer Research. ,vol. 14, pp. 2690- 2695 ,(2008) , 10.1158/1078-0432.CCR-07-1731
Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva, Valentina Donati, Fabio Petrocca, Patrizia Casalini, Cristian Taccioli, Stefano Volinia, Chang-Gong Liu, Hansjuerg Alder, George A. Calin, Sylvie Ménard, Carlo M. Croce, MicroRNA Signatures in Human Ovarian Cancer Cancer Research. ,vol. 67, pp. 8699- 8707 ,(2008) , 10.1158/0008-5472.CAN-07-1936
Jeffrey I. Zwicker, Howard A. Liebman, Donna Neuberg, Romaric Lacroix, Kenneth A. Bauer, Barbara C. Furie, Bruce Furie, Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clinical Cancer Research. ,vol. 15, pp. 6830- 6840 ,(2009) , 10.1158/1078-0432.CCR-09-0371